Newsroom News Archive Publications Contact Us for Experts  

News from:

2009

| 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | RSSFeeds  

NEWS RELEASE
MARCH 9, 2007
  Penn Study Suggests Test for Tumor Suppressor p53 Is Needed to Prescreen Patients for Blood Cancer Drugs
Back to Article
Image    1
   

Green staining depicts tumor cells dying after treatment with proteasome inhibitors. In the left panel, the tumor lacks p53, and only a fraction of the cells are killed. In the right panel, the tumor produces p53, resulting in massive cell death.

Image Credit: Andrei Thomas-Tikhonenko, PhD, University of Pennsylvania School of Medicine; Blood.

Download high-resolution version (512 KB, JPEG, 300 DPI)

Tumor Cells With and Without p53
 


About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine , Philadelphia, PA 1-800-789-PENN © 2009, The Trustees of the University of Pennsylvania